GlassScriptPhysician profile
Suzanne Gilberg-Lenz
NPI 1467492041
$316,430.24
in general payments reported to CMS, 2019-2025
43 companies · $544 in 2025
The $544 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,325 · 2020: $110K · 2021: $201K · 2022: $1,348 · 2023: $845 · 2024: $934 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,322.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bsn Medical INC | $310,000.00 | 2020-2021 | |
| Abbvie INC. | $1,495.82 | 2019-2025 | |
| Daiichi Sankyo INC. | $873.72 | 2019-2025 | Injectafer |
| Amag Pharmaceuticals, INC. | $415.72 | 2019 | |
| Scynexis, INC. | $407.31 | 2022 | |
| Evofem Biosciences, INC. | $398.36 | 2021-2025 | Phexxi, Solosec, Phexx |
| Therapeuticsmd, INC. | $340.32 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $299.92 | 2021-2025 | |
| Coopersurgical, INC. | $290.41 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $253.67 | 2019-2024 | |
| Allergan, INC. | $229.39 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $197.17 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $160.68 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $158.62 | 2021-2022 | |
| Exeltis, USA INC. | $87.97 | 2024 | Slynd |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $72.51 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $67.41 | 2023-2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $56.97 | 2020-2023 | Aptima, Coolseal Generator, Acessa Provu System |
| Baxter Healthcare | $48.95 | 2021 | |
| Vertical Pharmaceuticals, LLC | $45.50 | 2019-2020 | |
| Duchesnay USA Incorporated | $44.00 | 2019 | |
| Meditrina | $43.84 | 2024 | |
| Merck Sharp & Dohme LLC | $42.36 | 2023-2024 | Gardasil 9, Gardasil, Vaqta |
| Agile Therapeutics, INC. | $35.10 | 2023 | Twirla |
| Lilly USA, LLC | $33.35 | 2025 | Mounjaro, Zepbound |
| Amgen INC. | $28.68 | 2024 | Evenity, Prolia |
| Lupin INC. | $28.50 | 2019-2020 | |
| Heartflow, INC. | $27.40 | 2025 | |
| Biogen, INC. | $25.58 | 2024 | |
| Shield Therapeutics INC | $24.93 | 2022 | |
| Millicent US INC | $23.11 | 2025 | Femlyv, Intrarosa |
| Ferring Pharmaceuticals INC. | $20.24 | 2019 | |
| Medicem INC. | $19.03 | 2021 | |
| Avion Pharmaceuticals | $16.90 | 2023 | Balcoltra |
| Axonics, INC. | $15.81 | 2024 | Axonics |
| Minerva Surgical, INC | $15.64 | 2024 | |
| Mission Pharmacal Company | $14.84 | 2019 | |
| Becton, Dickinson and Company | $13.07 | 2023 | Bd Onclarity |
| Mycovia Pharmaceuticals, INC. | $12.98 | 2023 | Vivjoa |
| Endo Pharmaceuticals INC. | $12.61 | 2019 | |
| Ascend Therapeutics US, LLC | $11.97 | 2021 | |
| Covidien LP | $10.92 | 2019 | |
| Channel Medsystems, INC. | $8.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Gilberg-Lenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.